Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance


The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time. Small and Mediumsized Entrerprises (SMEs are put at very high risk by the slowdown or shutdown of economic life in their countries – exactly those companies who ensure the development of innovative solutions urgently required for counteracting the impacts of COVID-19 and for helping to control possible future outbreaks alike. In view of this situation, accelerated uptake of innovative technologies to tackle COVID-19 is most needed. In order to give an efficient and fast answer to this challenging situation, we propose building an Innovation Hub for the addressed technologies: an innovative open access platform to offer companies and reference laboratories the capabilities, expertise, networks and services required for the assessment, development, prototyping, testing, scaling-up, pilot production and market exploitation of innovative technologies to tackle COVID-19 pandemic. This approach will be based in the Open Innovation Test Beds (OITBs) concept, to incorporate lessons learned from those Innovation Actions, reducing time for putting in place such HUB and ensuring its successful implementation for a swift impact to the current situation. Our approach will include leading applied research and innovation centers in Europe, together with entities specialized in building OITBs, and reference clinical sites. INNO4COV19 will provide funding to third parties to help them achieve the desired objectives. Presence of leading applied research EU institutions in the Consortium will help to obtain a huge impact and to find and attract innovators across Europe to offer new solutions for COVID-19 pandemic and other potential future outbreaks. Europe needs to reinforce its technological leadership and rebuild an industrial sector capable to protect our citizen’s safety and well-being, and INNO4COV-19 will help in catalyzing the change.

Project details

Unibo Team Leader: Michele Bartoletti

Unibo involved Department/s:
Dipartimento di Scienze Mediche e Chirurgiche

Laboratorio Iberico Internacional De Nanotecnologia (Inl)(Portugal)

Other Participants:
Fundacion Vasca De Innovacion E Investigacion Sanitarias-Bioef (Spain)
Joanneum Research Forschungsgesellschaft Mbh (Austria)
Fraunhofer Ipa (Germany)
Biokeralty Research Institute Aie (Spain)
The Provost, Fellows, Foundation Scholars & The Other Members Of Board Of The College Of The Holy & Undivided Trinity Of Queen Elizabeth Near Dublin (Ireland)
Vlaamse Instelling Voor Technologisch Onderzoek N.V. (Belgium)
Obelis Sa (Belgium)
ALMA MATER STUDIORUM - Università di Bologna (Italy)
Acondicionamiento Tarrasense Associacion (Spain)
Instituto De Medicina Molecular Joao Lobo Antunes (Portugal)

Total Eu Contribution: Euro (EUR) 6.188.613,75
Project Duration in months: 24
Start Date: 01/10/2020
End Date: 30/09/2022

Cordis webpage
Project website

Good health and well-being This project contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.

UE flag This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101016203